1. Reform of public hospital: vigorously advance the total and complete restructuring of about 3000 non-governmental public hospitals in 3 years (excluding 375 military hospitals) and attract and encourage the active involvement of the social capital.
2. The added-value tax of traditional Chinese medicines hindering the industry development: accelerate the structural adjustment of pharmaceuticals industry and it is imperative to adjust and reform the unequal and unreasonable situation of the added-value tax of enterprises of Chinese patent medicines.
3. The list of national essential drugs to be consulted with the village doctors: (1) There must be the participation of the representative of the grass-roots doctors during amending essential drug list every year. (2) The essential drug must be marked with essential drug mark and retail price on the package.
4. Recommending the birthday of Li Shizhen to be the traditional Chinese medicine culture day: recommended by a member of the CPPCC: set the birthday (July 13) of Li Shizhen, a medicine expert in Ming Dynasty, as the traditional Chinese medicine culture day of our country to further strengthen the cultural construction of traditional Chinese medicine.
5. To realize legislation for traditional Chinese medicine as soon as possible: the member of the CPPCC expressed that it was hoped to realize legislation for traditional Chinese medicine as soon as possible to protect the intellectual property of traditional Chinese medicine; more and better impacts shall be generated through external exchange and increased publicity for the entire traditional Chinese medicines to make people understand some features and advantages of traditional Chinese medicines and avoid misunderstandings.
6. Accelerating the drug examination and approval once again becoming a hot spot of NPC & CPPCC: The problem of single examination and evaluation channel shall be settled by the method of third-party independent evaluation and then the government purchasing the service. The drug administration department must invite experts to make assessment during technical evaluation and review stage, and finally the drug administration is responsible for the examination and approval.